CDC Vaccine Related Patents
www.google.com/patents/US9248179
Grant - Filed Jun 23, 2011 - Issued Feb 2, 2016 - Xianfu Wu - The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Described herein are recombinant rabies viruses encoding rabies virus glycoprotein and at least one heterologous glycoprotein from another lyssavirus , such ...
Overview · Related · Discuss
www.google.com/patents/US8637050
Grant - Filed Mar 18, 2013 - Issued Jan 28, 2014 - Bernard W. Beall - The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention
In another aspect, it relates to compositions or vaccines comprising these synthetic serotype-specific peptides, including polypeptides and proteins.
Overview · Related · Discuss
www.google.com/patents/US7417136
Grant - Filed Jun 3, 1999 - Issued Aug 26, 2008 - Gwong-Jen J. Chang - The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention
The invention also encompasses a vaccine whose active agent is the nucleic acid. The invention further encompasses the cultured host cells when they contain ...
Overview · Related · Discuss
www.google.com/patents/US5212084
Grant - Filed Jun 1, 1988 - Issued May 18, 1993 - Harold M. McClure - Emory University
A retrovirus and related method used in producing a model for evaluating the antiretroviral effects of drugs and vaccines includes the steps of removing ...
Overview · Related · Discuss
www.google.com/patents/US7954486
Grant - Filed Apr 1, 2005 - Issued Jun 7, 2011 - Mark J. Papania - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
The present system can be used to administer various types of agents, such as a vaccine or other types of pharmaceutical substances. Certain embodiments of ...
Overview · Related · Discuss
www.google.com/patents/US7407664
Grant - Filed May 20, 2002 - Issued Aug 5, 2008 - Bernard W. Beall - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
In another aspect, it relates to compositions or vaccines comprising these synthetic serotype-specific peptides, including polypeptides and proteins.
Overview · Related · Discuss
www.google.com/patents/US6169175
Grant - Filed Aug 6, 1997 - Issued Jan 2, 2001 - A. Michael Frace - Centers For Disease Control And Prevention
Also provided are vaccines comprising variants of M2 expressed in prokaryotic hosts. Further provided are methods of preventing influenza A infection using ...
Overview · Related · Discuss
www.google.com/patents/US8221768
Grant - Filed Oct 15, 2009 - Issued Jul 17, 2012 - Gwong-Jen J. Chang - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Arroyo, J., et al., "Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (chimerivax-je) ...
Overview · Related · Discuss
www.google.com/patents/US7223836
Grant - Filed May 31, 2002 - Issued May 29, 2007 - Eric L. Marston - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Peptides are disclosed that include SEQ ID NO:1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6, or a conservative variant or mimic ...
Overview · Related · Discuss
www.google.com/patents/EP1002093B1?cl=en
Grant - Filed Aug 6, 1998 - Issued Apr 6, 2005 - A. Michael Frace - Centers for Disease Control & Prevention
Also provided are vaccines comprising variants of M2 expressed in prokaryotic hosts. Further provided are methods of preventing influenza A infection using ...
Overview · Related · Discuss
www.google.com/patents/US9046520
Grant - Filed Feb 10, 2011 - Issued Jun 2, 2015 - Vera A. Semenova - The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Baudner B.C., et al., "Enhancement of Protective Efficacy Following Intranasal Immunizationwith Vaccine Plus a Nontoxic LTK63 Mutant Delivered with ...
Overview · Related · Discuss
www.google.com/patents/US8846056
Grant - Filed Aug 4, 2010 - Issued Sep 30, 2014 - Larry J. Anderson - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control
Immunogenic polypeptides corresponding to one or more RSV G glycoproteins, or analogues thereof, are provided as components of vaccines. The inventive ...
Overview · Related · Discuss
www.google.com/patents/US7227011
Grant - Filed Apr 4, 2001 - Issued Jun 5, 2007 - Gwong-Jen J. Chang - United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. The invention ...
Overview · Related · Discuss
www.google.com/patents/US9102742
Grant - Filed Aug 27, 2013 - Issued Aug 11, 2015 - Vera A. Semenova - The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention
Regions of B. anthracis protective antigen are provided representing sequences recognized by antibodies in subjects that have vaccine induced lethal toxin ...
Overview · Related · Discuss
www.google.com/patents/CA2611934C?cl=en
Grant - Filed May 18, 2006 - Issued Nov 3, 2015 - Richard Kinney - Sanofi Pasteur
... 2018-01-30 Takeda Vaccines, Inc. Compositions, methods of administration and uses for trivalent dengue virus formulations.
Overview · Related · Discuss
www.google.com/patents/US5750329
Grant - Filed Jul 12, 1996 - Issued May 12, 1998 - Frederick D. Quinn - Centers For Disease Control And Prevention
Such studies can also provide useful information on the effectiveness of applications such as drug treatments and vaccines whose mechanism of action involves ...
Overview · Related · Discuss
www.google.com/patents/US8354115
Grant - Filed Apr 4, 2008 - Issued Jan 15, 2013 - Ralph A. Tripp - The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention
... vaccines against disease caused by RSV and parainfluenza virus (PIV),” Meeting Report, WHO Programme for Vaccine Development. Vaccine ...
Overview · Related · Discuss
www.google.com/patents/EP1053329B1?cl=en
Grant - Filed Jan 14, 1999 - Issued Oct 7, 2009 - Edwin W. Ades - Centers for Disease Control & Prevention
Also provided are vaccines comprising immunogenic lipidated PsaA proteins and methods of use of such vaccines in the prevention and treatment of ...
Overview · Related · Discuss
www.google.com/patents/US8524247
Grant - Filed Aug 20, 2009 - Issued Sep 3, 2013 - Xianfu Wu - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... and immunocontraceptive peptide-specific antibodies in vaccinated animals, and protect vaccinated animals against wild-type rabies virus challenge. Further ...
Overview · Related · Discuss
www.google.com/patents/US8105609
Grant - Filed May 16, 2008 - Issued Jan 31, 2012 - Gwong-Jen J. Chang - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
The invention also encompasses a vaccine whose active agent is the nucleic acid. The invention further encompasses the cultured host cells when they contain ...
Overview · Related · Discuss
www.google.com/patents/US8728488
Grant - Filed Dec 28, 2011 - Issued May 20, 2014 - Gwong-Jen J. Chang - The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention
The invention also encompasses a vaccine whose active agent is the nucleic acid. The invention further encompasses the cultured host cells when they contain ...
Overview · Related · Discuss
www.google.com/patents/US8067565
Grant - Filed Dec 8, 2009 - Issued Nov 29, 2011 - Richard Kinney - Sanofi Pasteur
... on PDK and sanitization on Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV1 strain.
Overview · Related · Discuss
www.google.com/patents/US7632510
Grant - Filed Jun 14, 2006 - Issued Dec 15, 2009 - Gwong-Jen J. Chang - The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention
The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. The invention ...
Overview · Related · Discuss
www.google.com/patents/US8232379
Grant - Filed Jul 24, 2009 - Issued Jul 31, 2012 - Gwong-Jen J. Chang - The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. The invention ...
Overview · Related · Discuss
www.google.com/patents/US7425611
Grant - Filed Mar 26, 2004 - Issued Sep 16, 2008 - Renu B. Lal - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... inducing an immune response to an immunodeficiency virus, such as HIV-1. The disclosure further relates to vaccines comprising immunogenic compounds.
Overview · Related · Discuss
www.google.com/patents/CA2426312C?cl=en - Translate this page
Grant - Filed Oct 18, 2001 - Issued Jan 14, 2014 - Ralph A. Tripp - Ralph A. Tripp
... Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation. EP1010692A1 ...
Overview · Related · Discuss
www.google.com/patents/US8663926
Grant - Filed Feb 15, 2007 - Issued Mar 4, 2014 - Anne E. Boyer - The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention
12 is bar graphs depicting LF levels in vaccinated animals following challenge by intranasal anthrax infection, with activity levels of LF determined by the present ...
Overview · Related · Discuss
www.google.com/patents/US8642048
Grant - Filed Jan 27, 2009 - Issued Feb 4, 2014 - Edwin W. Ades - The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Also provided are vaccines comprising such immunogenic peptides, and methods of conferring protective immunity against Streptococcus pneumoniae infection ...
Overview · Related · Discuss
www.google.com/patents/US8656908
Grant - Filed May 2, 2011 - Issued Feb 25, 2014 - Mark J. Papania - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
The present system can be used to administer various types of agents, such as a vaccine or other types of pharmaceutical substances. Certain embodiments of ...
Overview · Related · Discuss
www.google.com/patents/US8544462
Grant - Filed Apr 27, 2007 - Issued Oct 1, 2013 - Mark James Papania - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Fluid recycling in the nebulizer in the small amount of vaccine required for each dose results in the inability to operate on a dose-by-dose basis. Many doses ...
Overview · Related · Discuss
www.google.com/patents/US8865461
Grant - Filed Nov 30, 2010 - Issued Oct 21, 2014 - Charles E. Rupprecht - The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Although wildlife rabies still exists in developed countries, progress has been made in control and elimination of wildlife rabies using oral immunization of wild ...
Overview · Related · Discuss
www.google.com/patents/US8821409
Grant - Filed Dec 21, 2009 - Issued Sep 2, 2014 - David N. Ku - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
A device for collecting material from lung aerosols. The device functions by collecting aerosols from the lower airway separated from material in the by collecting ...
Overview · Related · Discuss
www.google.com/patents/US6472518
Grant - Filed Oct 24, 1997 - Issued Oct 29, 2002 - Efrain M. Ribot - Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services
However, preliminary data from vaccine trial studies suggests that these factors do not ... it is or importance to identify alternative serogroup B vaccine antigens.
Overview · Related · Discuss
www.google.com/patents/US8541221
Grant - Filed Jul 1, 2010 - Issued Sep 24, 2013 - William M. Switzer - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
The present disclosure also relates to vectors and vaccines for use in humans against infection and disease. The disclosure further relates to a variety of ...
Overview · Related · Discuss
www.google.com/patents/US7906292
Grant - Filed Jul 27, 2005 - Issued Mar 15, 2011 - Gwong-Jen J. Chang - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Small doses (ng level) of antigen administered at multiple intradermal sites appear to be most reliable. An effective immunization protocol for rabbits can be ...
Overview · Related · Discuss
www.google.com/patents/US8226952
Grant - Filed Apr 26, 2010 - Issued Jul 24, 2012 - William D. Thomas, Jr. - University Of Massachusetts
... immunization). Administration of multiple does of rabies vaccine (active immunization) ...
Overview · Related · Discuss
www.google.com/patents/US9650422
Grant - Filed Mar 16, 2015 - Issued May 16, 2017 - Gwong-Jen J. Chang - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Small doses (ng level) of antigen administered at multiple intradermal sites appear to be most reliable. An effective immunization protocol for rabbits can be ...
Overview · Related · Discuss
www.google.com/patents/US9435000
Grant - Filed Sep 20, 2013 - Issued Sep 6, 2016 - William M. Switzer - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
The present disclosure also relates to vectors and vaccines for use in humans against infection and disease. The disclosure further relates to a variety of ...
Overview · Related · Discuss
www.google.com/patents/US8846051
Grant - Filed Oct 7, 2005 - Issued Sep 30, 2014 - Olen M. Kew - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... vaccines ...
Overview · Related · Discuss
www.google.com/patents/US7220852
Grant - Filed Apr 12, 2004 - Issued May 22, 2007 - Paul A. Rota - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Small doses (ng level) of antigen administered at multiple intradermal sites appear to be most reliable. An effective immunization protocol for rabbits can be ...
Overview · Related · Discuss
www.google.com/patents/US7919104
Grant - Filed Jul 29, 2005 - Issued Apr 5, 2011 - Edwin W. Ades - The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention
... vaccines are available in the United States. However, countries with limited resources cannot afford these vaccines ...
Overview · Related · Discuss
www.google.com/patents/US7320881
Grant - Filed Apr 6, 2005 - Issued Jan 22, 2008 - Brent A. Lasker - The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Peptides or polypeptides encoded by the disclosed nucleotide sequences can be used for vaccines or to detect antibodies from a subject directed to the ...
Overview · Related · Discuss
www.google.com/patents/US8191552
Grant - Filed Nov 13, 2009 - Issued Jun 5, 2012 - Andrzej Przekwas - Cfd Research Corporation
... vaccine ...
Overview · Related · Discuss
www.google.com/patents/US9345758
Grant - Filed Apr 19, 2011 - Issued May 24, 2016 - Patti C. Crawford - University Of Florida Research Foundation, Inc.
... vaccines and methods for protecting canines from canine influenza, kits comprising such vaccines, and methods for using such vaccines ...
Overview · Related · Discuss
www.google.com/patents/US6756043
Grant - Filed Feb 5, 2002 - Issued Jun 29, 2004 - Victor C. W. Tsang - The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention
... vaccine ...
Overview · Related · Discuss
www.google.com/patents/DE60131962T2?cl=en
Grant - Filed Mar 30, 2001 - Issued Dec 11, 2008 - Ryan M. San Antonio GREENE - The Government Of The Usa Represented By The Department Of Health And Human Services Centers For Disease Control & Prevention
Immunological compositions, including immunological release compositions and vaccines, and other pharmaceutical compositions containing the T. solium ...
Overview · Related · Discuss
www.google.com/patents/EP1399181B1?cl=de
Grant - Filed May 20, 2002 - Issued May 9, 2012 - Bernard W. Beall - The Government of the USA, as represented by the Secretary, Dept. of Health and Human Services, Centers for Disease Control and Prevention
US7407664B2 * 2001-05-18 2008-08-05 ...
Overview · Related · Discuss
www.google.com/patents/US7727532
Grant - Filed Aug 2, 2007 - Issued Jun 1, 2010 - William D. Thomas, Jr. - University Of Massachusetts
... immunization). Administration of multiple does of rabies vaccine (active immunization) ...
Overview · Related · Discuss
www.google.com/patents/US9063150
Grant - Filed Aug 25, 2009 - Issued Jun 23, 2015 - Alison Jane Basile - The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control Prevention
... vaccination ...
Overview · Related · Discuss
www.google.com/patents/US7776521
Grant - Filed May 14, 2007 - Issued Aug 17, 2010 - Paul A. Rota - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
An effective immunization protocol for rabbits can be found in Vaitukaitis et al. ..... in the field of immune stimulatory compounds (for example, vaccines) ...
Overview · Related · Discuss
www.google.com/patents/US9096908
Grant - Filed Apr 26, 2010 - Issued Aug 4, 2015 - Kathleen M. Tatti - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Accurate identification of pertussis cases in respiratory disease outbreaks is of particular importance because some interventions, such as vaccination, are ...
Overview · Related · Discuss
www.google.com/patents/US7469186
Grant - Filed Mar 19, 2004 - Issued Dec 23, 2008 - Thomas H. Taylor, Jr. - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... Peter Kaastrup Vaccine chip technology exploiting immunostimulating fragment of TGF-BETA. US6514770B1 ...
Overview · Related · Discuss
www.google.com/patents/US7368256
Grant - Filed Aug 9, 2002 - Issued May 6, 2008 - Detlef Schmechel - United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Serum protein formed in response to immunization. An immunoglobin molecule that has an amino acid sequence by virtue of which it interacts with the antigen ...
Overview · Related · Discuss
www.google.com/patents/US8357525
Grant - Filed Sep 4, 2008 - Issued Jan 22, 2013 - Baoming Jiang - The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Vaccine compositions and methods of vaccinating a subject against rotavirus are provided which include generation and use of thermally inactivated rotavirus.
Overview · Related · Discuss
www.google.com/patents/CA2611954C?cl=en
Grant - Filed Jun 7, 2006 - Issued Jan 28, 2014 - Richard Kinney - Sanofi Pasteur
The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain ...
Overview · Related · Discuss
www.google.com/patents/US8673316
Grant - Filed Aug 18, 2011 - Issued Mar 18, 2014 - Richard M. Kinney - The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention
The attenuated chimeric viruses are effective as immunogens or vaccines and may be combined in a pharmaceutical composition to confer simultaneous ...
Overview · Related · Discuss
www.google.com/patents/US8715689
Grant - Filed Apr 27, 2009 - Issued May 6, 2014 - Claire Y. H. Kinney - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Also disclosed are methods of using the chimeric viruses in diagnosis of Dengue viral infection, assessment of candidate Dengue virus vaccine efficacy, and ...
Overview · Related · Discuss
www.google.com/patents/DE60205093T2?cl=en
Grant - Filed Mar 13, 2002 - Issued May 24, 2006 - C. Mark BAGLEY - Creare Inc.
For example, many patients can be immunized with an inhaled vaccine composition using the present disclosure without the need for needles or reloading of the ...
Overview · Related · Discuss
www.google.com/patents/US8420607
Grant - Filed Dec 24, 2008 - Issued Apr 16, 2013 - Russell W. Carlson - University Of Georgia Research Foundation, Inc.
The present invention includes a vaccine including an isolated trisaccharide having a β-Gal-(1→4)-α-GlcNAc-(1→O) disaccharide, wherein the α-GlcNAc ...
Overview · Related · Discuss
www.google.com/patents/US7225807
Grant - Filed Mar 13, 2002 - Issued Jun 5, 2007 - Mark James Papania - Creare Incorporated
The inefficiency of the jet nebulizer poses problems to its use for aerosol vaccination. High velocity is needed in the air jet to provide the energy required to break ...
Overview · Related · Discuss
www.google.com/patents/CA2478371C?cl=en
Grant - Filed Mar 10, 2003 - Issued Dec 31, 2013 - Harriet L. Robinson - Emory University
We have developed DNA and viral vectors that can be used, alone or in combination, as a vaccine against one HIV clade, subtype, or recombinant form of HIV or ...
Overview · Related · Discuss
www.google.com/patents/US8426574
Grant - Filed May 28, 2010 - Issued Apr 23, 2013 - David Wang - Washington University
For use as a vaccine, compositions comprising a polypeptide of SEQ ID NO:7 or a characteristic immunogenic portion thereof are preferred, as these represent ...
Overview · Related · Discuss
www.google.com/patents/US7223535
Grant - Filed Dec 16, 2003 - Issued May 29, 2007 - Howard A. Fields - Centers For Disease Control
These tests utilize intact HAV, and therefore indiscriminately detect both natural and vaccineinduced immune responses. New concepts enabling the design of ...
Overview · Related · Discuss
www.google.com/patents/US7959929
Grant - Filed Oct 19, 2006 - Issued Jun 14, 2011 - Patti C. Crawford - University Of Florida Research Foundation, Inc.
... vaccines and methods for protecting canines from canine influenza, kits comprising such vaccines, and methods for using such vaccines ...
Overview · Related · Discuss
www.google.com/patents/US7595059
Grant - Filed Aug 21, 2006 - Issued Sep 29, 2009 - Victor C. W. Tsang - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Yeasts are beneficial hosts for vaccine or pharmaceutical product expression. Production and purification of the gene product may be achieved and enhanced ...
Overview · Related · Discuss
www.google.com/patents/US8663968
Grant - Filed May 20, 2008 - Issued Mar 4, 2014 - William M. Switzer - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Immunization by nucleic acid constructs is well known in the art and taught, for example, in U.S. Pat. No. 5,643,578 (which describes methods of immunizing ...
Overview · Related · Discuss
www.google.com/patents/US8986933
Grant - Filed Dec 5, 2008 - Issued Mar 24, 2015 - Xiaoyan Lu - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control
... Anderson, G. A. Weinberg, C. B. Hall, M. K. Iwane, K. M. Edwards, and New VaccineSurveillance Network. 2007. Rhinovirus-associated hospitalizations in ...
Overview · Related · Discuss
www.google.com/patents/US7863041
Grant - Filed Oct 13, 2006 - Issued Jan 4, 2011 - Charles E. Rupprecht - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Although wildlife rabies still exists in developed countries, progress has been made in control and elimination of wildlife rabies using oral immunization of wild ...
Overview · Related · Discuss
www.google.com/patents/US8592146
Grant - Filed Sep 4, 2012 - Issued Nov 26, 2013 - Jeffrey A. Johnson - Centers For Disease Control And Prevention
The model offers a unique setting for mutation detection testing, preclinical evaluation of drugs, vaccines and gene-therapies against HIV, and can identify many ...
Overview · Related · Discuss
www.google.com/patents/CA2576798C?cl=en
Grant - Filed Jul 27, 2005 - Issued Sep 9, 2014 - Gwong-Jen J. Chang - Gwong-Jen J. Chang
One specific example of a type of immune stimulatory composition is a vaccine. In some embodiments, an "effective amount" or "immune-stimulatory amount" of ...
Overview · Related · Discuss
www.google.com/patents/US6030771
Grant - Filed Aug 25, 1997 - Issued Feb 29, 2000 - Yury E. Khudyakov - Centers For Disease Control And Prevention
... vaccination ...
Overview · Related · Discuss
www.google.com/patents/US8431134
Grant - Filed Jul 31, 2009 - Issued Apr 30, 2013 - Edwin W. Ades - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... 2008; 44:186-96; Romero-Steiner et al., Vaccine 2006; 24:3224-31). The pure peptides with a free N- and C-terminus were synthesized and lyophilized at the ...
Overview · Related · Discuss
www.google.com/patents/US9101582
Grant - Filed Mar 27, 2013 - Issued Aug 11, 2015 - Edwin W. Ades - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... 2008; 44:186-96; Romero-Steiner et al., Vaccine 2006; 24:3224-31). The pure peptides with a free N- and C-terminus were synthesized and lyophilized at the ...
Overview · Related · Discuss
www.google.com/patents/US9000141
Grant - Filed Sep 28, 2010 - Issued Apr 7, 2015 - Gwong-Jen J. Chang - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
Small doses (ng level) of antigen administered at multiple intradermal sites appear to be most reliable. An effective immunization protocol for rabbits can be ...
Overview · Related · Discuss
www.google.com/patents/CA2735543C?cl=en
Grant - Filed Aug 25, 2009 - Issued May 2, 2017 - Alison Jane Basile - Alison Jane Basile
... vaccinated ...
Overview · Related · Discuss
www.google.com/patents/CA2517198C?cl=en
Grant - Filed Mar 19, 2004 - Issued Jun 21, 2016 - Thomas H. Taylor, Jr. - The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... Vaccine Chip Technology Aps Immunostimulating properties of a fragment of ... vaccinescomprising said antigen, anthrax-specific antibodies, and their uses.
Overview · Related · Discuss
www.google.com/patents/CA2687375C?cl=en
Grant - Filed May 16, 2008 - Issued Aug 29, 2017 - Lesley Mcgee - The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
laboratories (Streptococcus Laboratory, Respiratory Diseases Branch and Molecular Sequencing Laboratory, Meningitis and Vaccine Preventable Diseases ...
Overview · Related · Discuss
www.google.com/patents/CA2598547C?cl=en
Grant - Filed Feb 21, 2006 - Issued Jan 19, 2016 - Donald Burke - The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
The present invention also relates to vectors and vaccines for use in humans against infection and disease. The invention further relates to a variety of bioassays ...
Overview · Related · Discuss
www.google.com/patents/US8357488
Grant - Filed May 16, 2008 - Issued Jan 22, 2013 - Lesley McGee - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... ジェノセア バイオサイエンシーズ， インコーポレイテッド Vaccines ...
Overview · Related · Discuss
www.google.com/patents/US7933721
Grant - Filed Jan 20, 2006 - Issued Apr 26, 2011 - Alison Jane Johnson - The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention
Davis et al., "West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses in Vitro a Noninfectious Recombinant ...
Overview · Related · Discuss
www.google.com/patents/DE60020143T2?cl=en
Grant - Filed Mar 24, 2000 - Issued Feb 23, 2006 - R. David KILPATRICK - THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Centers for Disease Control and Prevention, Office of Technology Transfer, Atlanta
... vaccine ...
Overview · Related · Discuss
www.google.com/patents/US8318428
Grant - Filed Jan 24, 2012 - Issued Nov 27, 2012 - Jeffrey A. Johnson - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... testing, preclinical evaluation of drugs, vaccines and gene-therapies against HIV, and can identify many virus and host determinants of lentiviral disease.
Overview · Related · Discuss
www.google.com/patents/DE69836968T2?cl=de - Translate this page
Grant - Filed Aug 21, 1998 - Issued Oct 31, 2007 - A. Howard Marietta FIELDS - The Government of the United States of America, as represented by the Secretary, Technology Transfer Office, Centers for Disease Control and Prevention
... vaccines ...
Overview · Related · Discuss
www.google.com/patents/US8043809
Grant - Filed Jun 7, 2005 - Issued Oct 25, 2011 - Jeffrey A. Johnson - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
The model offers a unique setting for mutation detection testing, preclinical evaluation of drugs, vaccines and gene-therapies against HIV, and can identify many ...
Overview · Related · Discuss
www.google.com/patents/US8859742
Grant - Filed Nov 2, 2010 - Issued Oct 14, 2014 - Yu Li - The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention
... nodular lesions was tested to rule out the possible infection with the oral rabies vaccine (a live vaccinia-rabies glycoprotein recombinant virus) (Hanlon et al., ...
Overview · Related · Discuss
www.google.com/patents/EP1851315B1?cl=de
Grant - Filed Feb 2, 2006 - Issued Dec 25, 2013 - William D. Thomas, Jr. - University of Massachusetts
Administration of multiple does of rabies vaccine (active immunization), usually in the form of a first dose followed by subsequent booster doses, allow for the ...
